ISDA: 4C68

Deposition Date 2013-09-17

Release Date 2014-09-24

Last Version Date 2024-05-08

Entry Detail

PDB ID:

4C68

Keywords:

TRANSFERASE

Title:

Plasmodium vivax N-myristoyltransferase in complex with a peptidomimetic inhibitor

Biological Source:

Source Organism(s):

PLASMODIUM VIVAX (Taxon ID: 5855)

Expression System(s):

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.38 Å

R-Value Free:

0.25

R-Value Work:

0.21

R-Value Observed:

0.22

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE
Gene (Uniprot):PVX_085815
Chain IDs:A, B, C
Chain Length:384
Number of Molecules:3
Biological Source:PLASMODIUM VIVAX

UniProt ID:A5K1A2 Pfam ID:PF01233, PF02799 EC:2.3.1.97

Ligand Molecules

DMS

EN5

FMT

NHW

SO4

Primary Citation

Peptidomimetic Inhibitors of N-Myristoyltransferase from Human Malaria and Leishmaniasis Parasites.

Olaleye, T.O, Brannigan, J.A, Roberts, S.M, Leatherbarrow, R.J, Wilkinson, A.J, Tate, E.W.Show

Org.Biomol.Chem. 12 8132 ? (2014)

PMID: 25230674 DOI: 10.1039/C4OB01669F

Abstact

N-Myristoyltransferase (NMT) has been shown to be essential in Leishmania and subsequently validated as a drug target in Plasmodium. Herein, we discuss the use of antifungal NMT inhibitors as a basis for inhibitor development resulting in the first sub-micromolar peptidomimetic inhibitors of Plasmodium and Leishmania NMTs. High-resolution structures of these inhibitors with Plasmodium and Leishmania NMTs permit a comparative analysis of binding modes, and provide the first crystal structure evidence for a ternary NMT-Coenzyme A/myristoylated peptide product complex.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form